HUP0200393A2 - Use of pharmaceutical composition containing n,n-dimethyl-1-[1-(4chlorophenyl)cyclobutyl]-3-methylbutylamine for controlling weight gain associated with therapeutic drugs - Google Patents

Use of pharmaceutical composition containing n,n-dimethyl-1-[1-(4chlorophenyl)cyclobutyl]-3-methylbutylamine for controlling weight gain associated with therapeutic drugs

Info

Publication number
HUP0200393A2
HUP0200393A2 HU0200393A HUP0200393A HUP0200393A2 HU P0200393 A2 HUP0200393 A2 HU P0200393A2 HU 0200393 A HU0200393 A HU 0200393A HU P0200393 A HUP0200393 A HU P0200393A HU P0200393 A2 HUP0200393 A2 HU P0200393A2
Authority
HU
Hungary
Prior art keywords
methylbutylamine
cyclobutyl
dimethyl
pharmaceutical composition
composition containing
Prior art date
Application number
HU0200393A
Other languages
English (en)
Inventor
Carl M Mendel
Timothy B Seaton
Steve P Weinstein
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of HUP0200393A2 publication Critical patent/HUP0200393A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0200393A 1999-03-19 2000-03-17 Use of pharmaceutical composition containing n,n-dimethyl-1-[1-(4chlorophenyl)cyclobutyl]-3-methylbutylamine for controlling weight gain associated with therapeutic drugs HUP0200393A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12534099P 1999-03-19 1999-03-19

Publications (1)

Publication Number Publication Date
HUP0200393A2 true HUP0200393A2 (en) 2002-08-28

Family

ID=22419292

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200393A HUP0200393A2 (en) 1999-03-19 2000-03-17 Use of pharmaceutical composition containing n,n-dimethyl-1-[1-(4chlorophenyl)cyclobutyl]-3-methylbutylamine for controlling weight gain associated with therapeutic drugs

Country Status (20)

Country Link
US (1) US6376552B1 (hu)
EP (1) EP1162965A1 (hu)
JP (1) JP2002539251A (hu)
KR (1) KR20020000784A (hu)
CN (1) CN1353603A (hu)
AU (1) AU3757800A (hu)
BG (1) BG105997A (hu)
BR (1) BR0009159A (hu)
CA (1) CA2367021A1 (hu)
CZ (1) CZ291864B6 (hu)
HU (1) HUP0200393A2 (hu)
IL (1) IL145241A0 (hu)
MX (1) MXPA01009467A (hu)
NO (1) NO20014480L (hu)
NZ (1) NZ514009A (hu)
PL (1) PL350919A1 (hu)
SK (1) SK13352001A3 (hu)
TR (1) TR200102695T2 (hu)
WO (1) WO2000056313A1 (hu)
ZA (1) ZA200107692B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002019998A2 (en) * 2000-09-08 2002-03-14 Eli Lilly And Company A method of treating weight gain associated with atypical antipsychotic use
BR0315084A (pt) * 2002-10-05 2005-08-16 Hanmi Pharm Ind Co Ltd Composição farmacêutica compreendendo hemiidrato cristalino de metanossulfonato de sibutramina
US20050131074A1 (en) * 2003-08-04 2005-06-16 Beckman Kristen M. Methods for treating metabolic syndrome
US20060035827A1 (en) * 2004-06-24 2006-02-16 Green Gary M Compositions and methods for the treatment or prevention of gallbladder disease
KR20060080818A (ko) 2005-01-06 2006-07-11 씨제이 주식회사 시부트라민의 술폰산염
KR20060080817A (ko) 2005-01-06 2006-07-11 씨제이 주식회사 시부트라민의 디카복실산염
JP2008526836A (ja) * 2005-01-06 2008-07-24 シージェー チェイルジェダン コーポレーション シブトラミンの無機酸塩
KR20060093564A (ko) * 2005-02-22 2006-08-25 종근당바이오 주식회사 무수 시부트라민 말산염 및 이의 제조 방법
KR100627687B1 (ko) * 2005-04-20 2006-09-25 주식회사 씨티씨바이오 시부트라민 유리염기 함유 조성물 및 이의 제조방법
JP2010503709A (ja) * 2006-09-15 2010-02-04 レビバ ファーマシューティカルズ，インコーポレーテッド シクロアルキルメチルアミンの合成、使用方法および組成物
BRPI0716002A2 (pt) * 2006-11-22 2013-07-30 Sk Chemicals Co Ltd complexo de inclusço, processo de preparaÇço de um complexo de inclusço e composiÇço de tratamento e prevenÇço de hipocondria e obesidade

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
CA2367021A1 (en) 2000-09-28
WO2000056313A1 (en) 2000-09-28
IL145241A0 (en) 2002-06-30
ZA200107692B (en) 2002-12-18
BG105997A (en) 2002-06-28
PL350919A1 (en) 2003-02-10
AU3757800A (en) 2000-10-09
CZ291864B6 (cs) 2003-06-18
JP2002539251A (ja) 2002-11-19
SK13352001A3 (sk) 2002-03-05
MXPA01009467A (es) 2004-03-19
KR20020000784A (ko) 2002-01-05
EP1162965A1 (en) 2001-12-19
TR200102695T2 (tr) 2002-01-21
CN1353603A (zh) 2002-06-12
NZ514009A (en) 2001-09-28
NO20014480D0 (no) 2001-09-14
NO20014480L (no) 2001-11-02
BR0009159A (pt) 2001-12-26
US6376552B1 (en) 2002-04-23
CZ20013283A3 (cs) 2002-07-17

Similar Documents

Publication Publication Date Title
AP1818A (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
ZA200405657B (en) Formulation & dosage form for the controlled delivery of therapeutic agents.
HK1046240A1 (en) Pharmaceutical compositions for the treatment of insulin resistance
HK1077832A1 (en) 17a-ALKYL-17ß-OXY-ESTRATRIENES AND INTERMEDIATES FOR THE FRODUCTION THEREOF, AND USE OF SAID 17a-ALKYL-17ß-OXY-ESTRATRIENES FOR PRODUCING MEDICAMENTS AND PHARMACEUTICAL PREPARATIONS
HUP0700039A2 (en) Use of cannabinoid drugs for the preparation of medicines for decreasing cell proliferation
HUP0200393A2 (en) Use of pharmaceutical composition containing n,n-dimethyl-1-[1-(4chlorophenyl)cyclobutyl]-3-methylbutylamine for controlling weight gain associated with therapeutic drugs
AU2513900A (en) Drug dosage unit for buccal administration of steroidal active agents
IL159151A0 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
CA2386690A1 (en) Pharmaceutical tramadol salts
AU2003295614A1 (en) Delivery of pharmaceutical agents via the human insulin receptor
HK1048986A1 (en) 2'-Substituted 1,1'-iphenyl-2-carbonamides, methodfor the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds.
PL367883A1 (en) Pharmaceutical formulation for the efficient administration of apomorphine, 6ar-(-)-n-propyl-norapomorphine and their derivatives and pro-drugs thereof
PL398391A1 (pl) Koniugat hydroksyalkiloskrobi i polipeptydu, sposób wytwarzania tego koniugatu, jego zastosowanie oraz kompozycja farmaceutyczna zawierająca koniugat hydroksyalkiloskrobi i polipeptydu
IL159345A0 (en) Active ingredient combination for pharmacological addictive substances or intoxicant therapy
GR20020100478A (el) Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης
IL206566A0 (en) Use of an antagonist to the igs4 neuromedin receptor polypeptide for the preparation of a medicament for the treatment of a disease related to the expression or acitivity of the igs4 neuromedin receptor polypeptide
WO2000056315A8 (en) Treatment of pain
AU2001258443A1 (en) Drug delivery device, especially for the delivery of gestodene
HUP0500958A3 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them, therapeutic use thereof and pharmaceutical compositions containing them
AU3971500A (en) Indazole derivatives, preparation and therapeutic application thereof
IL162385A (en) Benzothiazole - and benzoxazole - 4,7 - dione derivatives, uses thereof for the preparation of a medicament, medicaments containing them and pharmaceutical compositions containing them
HUP0200501A2 (en) Use of n,n-dimethyl-1-[1-(4chlorophenyl)cyclobutyl]-3-methylbutylamine for treating sleep apnoea
AU2001258442A1 (en) Drug delivery device, especially for the delivery of levonorgestrel
HUP0202647A3 (en) Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them
PL369632A1 (en) Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof